SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-250389
Filing Date
2010-11-08
Accepted
2010-11-05 18:04:05
Documents
7
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 535751
2 SECOND AMENDMENT TO BRISBANE TECHNOLOGY PARK LEASE dex101.htm EX-10.1 70768
3 THIRD AMENDMENT TO BRISBANE TECHNOLOGY PARK LEASE dex102.htm EX-10.2 16920
4 FOURTH AMENDMENT TO BRISBANE TECHNOLOGY PARK LEASE dex103.htm EX-10.3 28510
5 CERTIFICATION OF CEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 9290
6 CERTIFICATION OF CFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9336
7 CERTIFICATION OF CEO AND CFO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4602
  Complete submission text file 0001193125-10-250389.txt   676669
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

IRS No.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29801 | Film No.: 101170131
SIC: 2834 Pharmaceutical Preparations